Exchange: NASDAQ·Updated 10:10 AM EDT
INMB logo

INMB INmune Bio Inc

$2.32
$0.05
(2.20%)
Today
Reported EarningsAug 6
Mkt Cap$63M
Vol39,521.00

About INMB

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.
30

Bearish Sentiment

How do you feel about INMB?

Advertisement|Remove ads.